These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 90085)

  • 1. Alloantigen bound to agarose beads and syngeneic carrier cells are capable of stimulating mouse cytolytic T lymphocytes in vitro.
    Fast LD; Fan DP
    J Immunol; 1979 Oct; 123(4):1491-6. PubMed ID: 90085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociated and reconstituted subcellular alloantigen capable of stimulating mouse cytotoxic T lymphocytes in vitro.
    Fast LD; Fan DP
    J Immunol; 1978 Apr; 120(4):1092-6. PubMed ID: 76659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
    Fan J; Ahmed A; Bonavida B
    J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
    [No Abstract]   [Full Text] [Related]  

  • 10. Enumeration of alloreactive helper T lymphocytes which cooperate with cytolytic T lymphocytes.
    Lutz CT; Glasebrook AL; Fitch FW
    Eur J Immunol; 1981 Sep; 11(9):726-34. PubMed ID: 6975213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
    McKisic MD; Lancki DW; Fitch FW
    J Immunol; 1993 May; 150(9):3793-805. PubMed ID: 8097225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens.
    Cerottini JC; MacDonald HR
    J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245
    [No Abstract]   [Full Text] [Related]  

  • 14. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
    Fink PJ; Rammensee HG; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants.
    Suzan M; Bourgois A; Boned A; De Preval C; Golstein P; Rubin B
    J Immunol; 1981 Sep; 127(3):992-9. PubMed ID: 6167637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generation of cytolytic activity in mixed leukocyte cultures: cortisone-resistant thymocytes are deficient in helper T lymphocytes.
    Lutz CT
    J Immunol; 1981 Sep; 127(3):1156-63. PubMed ID: 6455469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting dilution analysis of alloantigen-reactive T lymphocytes. III. Effect of priming on precursor frequencies.
    Ryser JE; MacDonald HR
    J Immunol; 1979 Jul; 123(1):128-32. PubMed ID: 156230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytolytic T lymphocyte activity with subcellular alloantigen preparations and with unlabeled allogeneic target cells.
    Linna TJ; Engers HD; Cerottini JC; Brunner KT
    J Immunol; 1978 May; 120(5):1544-9. PubMed ID: 77875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.